Iron-Chelation
Beliefs of Jordanian Children with Thalassemia toward Using Iron Chelation Therapy
11
Is Iron Chelation Therapy Useful in Persons with Myelodysplastic Syndrome Receive?
5
Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program
12
Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions
13
Effects of Hypoxia and Iron Chelation on the Metabolism of the Amyloid Precursor Protein in Retinal Pigmented Epithelial Cells.
156
Ceruloplasmin activity and iron chelation treatment of patients with Parkinson’s disease
6
Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry
36
EVALUATION OF OSTEOPATHY IN PATIENTS WITH BETA THALASSEMIA MAJOR USING DIFFERENT IRON CHELATION THERAPIES
5
Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes
6
On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure
9
Curcumin Inhibits Growth of Saccharomyces cerevisiae through Iron Chelation
8
Oral iron chelation therapy with deferiprone (L1)
208
Combined Oral and Parenteral Iron Chelation in Beta Thalassaemia Major
5
Qualitative modification and development of patient- and caregiver-reported outcome measures for iron chelation therapy
13
Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes
17
Psychosocial factors influencing adherence to iron chelation therapy in patients with thalassaemia
165
Curcumin induces apoptosis and protective autophagy in castration-resistant prostate cancer cells through iron chelation
9
Estimates of the effect on hepatic iron of oral deferiprone compared with subcutaneous desferrioxamine for treatment of iron overload in thalassemia major: a systematic review
9
Abstract: Thalassemia is genetic blood disease cause by absence or decrease of one or more of
31
Antioxidant Studies on the Ethanolic Extract of Zornia Gibbosa
12